Tumor response and clinical benefit in neuroendocrine tumors after 7.4 GBq (90)Y-DOTATOC - Waldherr, C; Pless, M; Maecke, H R; Schumacher, T; Crazzolara, A; Nitzsche, E U; Haldemann, A; Mueller-Brand, J (J Nucl Med, 2002)